Cyclerion Therapeutics Inc. (CYCN)
NASDAQ · Healthcare
Cyclerion Therapeutics Inc. EPS 2019–2025
Cyclerion Therapeutics Inc. annual/quarterly eps history and growth rate from 2021 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Cyclerion Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.76, a 35.71% increase year-over-year.
- Cyclerion Therapeutics Inc. annual eps for 2025 was $1.11, a 8.26% decrease from 2024.
- Cyclerion Therapeutics Inc. annual eps for 2024 was $1.21, a 46.22% decrease from 2023.
- Cyclerion Therapeutics Inc. annual eps for 2023 was $2.25, a 88.91% decrease from 2022.
- Cyclerion Therapeutics Inc. annual eps for 2022 was $20.28.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Cyclerion Therapeutics Inc. EPS — FAQ
Cyclerion Therapeutics Inc. (CYCN) eps over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclerion Therapeutics Inc.'s eps?
Cyclerion Therapeutics Inc. (CYCN) reported eps of $-1.11 for fiscal 2025.
Where can I see CYCN's eps history?
The chart and table above show Cyclerion Therapeutics Inc.'s eps by year and by quarter, including the growth rate.